mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.03 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.03 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.04 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.04 |